Individuals with HIV who were resistant to all four antiretroviral drug classes experienced higher mortality than those who were not resistant, a difference primarily due to lower CD4 cell counts.

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for ...

Leading epidemiologists have warned that continued disruption to foreign aid funding, namely the sudden pause to the US President’s Emergency Plan for AIDS Relief (PEPFAR), could see a rise in the ...

A Gilead Sciences drug that protects against HIV infection has won a highly anticipated FDA approval, becoming the first medication for HIV prevention available as a twice-yearly injection. The ...

Pharmaceutical manufacturers and distributors will now have to explain to the state of Minnesota why 10 classes of drugs that treat cancer and other disorders are selling well above their listed costs ...